Title : First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.

Pub. Date : 2021 Oct

PMID : 33757737






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients with >=1% PD-L1 expression, the highest likelihood of better PFS was associated with lenvatinib plus pembrolizumab and nivolumab plus ipilimumab. lenvatinib CD274 molecule Homo sapiens